Nel ASA's Numbers Tell Two Stories — and Investors Are Left Weighing Which One Matters

Nel ASA's Q2 shows a 224% order intake surge to NOK 230M, yet revenue fell 12% and losses widened, with CEO departure and weak stock weighing.

There is a curious tension at the heart of Nel ASA's latest financial disclosures. The Norwegian hydrogen specialist booked a 224 percent surge in order intake during the second quarter, reaching 230 million Norwegian kroner, while its revenue line headed in the opposite direction with a 12 percent decline. That divergence — demand arriving faster than it can be converted into billable work — has become the defining feature of the company's current chapter.

The backlog now stands at roughly 1.21 billion kroner, a figure that suggests the pipeline is healthy. Yet the income statement tells a less forgiving story. EBITDA came in at minus 155 million kroner, and the net loss widened to 189 million kroner. Revenue from customer contracts landed at just 153 million kroner for the quarter, a figure that underscores how much ground the company must cover before its order book translates into sustainable profitability.

A 70 million kroner compensation payment to Japanese partner Iwatani added further strain to the quarter's results, while cash reserves contracted to 1.33 billion kroner. The combination of a swelling order book and a shrinking balance sheet leaves Nel in a position where growth and liquidity are pulling in opposite directions.

The Leadership Question Lingers

Compounding the operational pressure is the unresolved matter at the top of the organization. CEO Håkon Volldal announced his resignation in mid-June, but his departure is governed by a six-month notice period, meaning he remains in post until at least the end of the year. No successor has been named, leaving the company's strategic direction in a state of suspended animation.

That uncertainty has registered in the share price. Since the resignation was announced, the stock has shed 19 percent. The absence of a permanent chief executive is hardly an inviting prospect for potential candidates either — whoever steps in will inherit a restructuring story in which operational weakness and market headwinds are intertwined. The broader electrolyser market remains under pressure, which does little to make the role more attractive.

JPMorgan's recent reassessment of the stock has added to the cautious tone. The bank cut its price target to 1.80 kroner from 2.90 kroner roughly three weeks ago while maintaining a "Neutral" rating. Though the call is now somewhat dated, it continues to shape how the market frames the stock.

A Share Price Caught Between Hope and Reality

The equity itself has been drifting sideways with a downward bias. The most recent close came in at 0.1936 euros, down 0.4 percent on the day. That leaves the shares about 47 percent below their 52-week high — a gap that captures the market's skepticism about the company's near-term trajectory.

The technical picture reinforces the caution. The stock trades nearly 9 percent below its 200-day moving average of 0.2142 euros, a signal that the medium-term trend remains pointed lower. From the year's peak of 0.3655 euros, reached in May, the shares have retreated roughly 46 percent.

A calendar entry on Euronext for today has drawn some attention, though its significance is unclear. Whether it delivers substantive news or proves to be a procedural formality remains to be seen. Investors are likely to scrutinize any update for signs that the pattern of rising orders and persistent losses is shifting.

For now, Nel ASA finds itself in a holding pattern defined by two competing narratives: an order book that speaks to genuine demand for hydrogen technology, and a financial profile that has yet to prove the business can convert that demand into profit. The resolution of the leadership question and the pace at which the backlog converts into revenue will determine which story ultimately wins out.